Single administration of travoprost intraocular implant may effectively lower IOP over 3 years
Single administration of travoprost intraocular implant may effectively lower IOP over course of 3 years suggests a new study published in the Drugs. A travoprost intraocular implant may effectively lower intraocular pressure (IOP) over the course of 36 months after a single administration, according to new findings, substantially diminishing the necessity of topical IOP-lowering medications […]